Crossmark

Autonomic debate: symptoms are an optimal target for orthostatic hypotension screening and management. An argument in opposition

Published Online: 2026-02-28

Published Print: 2026-06

Authors

Beach, Paul A. https://orcid.org/0000-0002-3657-7106
Funding

Funding for this research was provided by:

National Center for Advancing Translational Sciences (KL2TR002381)
License Information

Text and Data Mining valid from 2026-02-28

Version of Record valid from 2026-02-28
More Information

Article History

Received: 29 December 2025

Accepted: 11 February 2026

First Online: 28 February 2026

Declarations

:

: None. Dr. Beach has served as a consultant for Theravance Biopharma and Lundbeck. Dr. Beach has received honoraria from the American Academy of Neurology.

Document is current